SSSilvana Soto-Rodriguez

Silvana Soto-Rodriguez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Silvana Soto-Rodriguez has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Redox resilience in skeletal muscle aging: cellular adaptations and exercise-mediated homeostasis

    by Eva Tamayo-Torres, Miriam Martinez-Canton, Silvana Soto-Rodriguez, Abril Gorgori-Gonzalez, Julian Carretero, Juan Ignacio Cervera-Miguel, Olga Laosa, Leocadio Rodriguez-Mañas, Maria Carmen Gomez-Cabrera

  • Top Cited Papers
    Open Access

    Leveraging mitochondrial stress to improve healthy aging

    by Abril Gorgori-Gonzalez, Silvana Soto-Rodriguez, Eva Tamayo-Torres, Esther Garcia-Dominguez, Vicente Sebastia, Juan Gambini, Gloria Olaso-Gonzalez, Maria Carmen Gomez-Cabrera

    Aging is characterized by a progressive decline in physiological function, driven by intrinsic mechanisms (primary aging) and modifiable factors (secondary aging), ultimately leading to multimorbidity, disability, and mortality. Mitochondrial dysfunction, a major hallmark of aging, plays a central role in the loss of muscle mass and strength observed in frailty and sarcopenia. With age, mitochondrial quality control processes, including biogenesis, mitophagy, and dynamics, become dysregulated, impairing energy metabolism and muscle homeostasis.


  • Open Access

    Osteoporosis: Causes, Mechanisms, Treatment and Prevention: Role of Dietary Compounds

    by Kristine Stromsnes, Cristian Martinez Fajardo, Silvana Soto-Rodriguez, Erika Ria Ulrika Kajander, Remus-Iulian Lupu, Monica Pozo-Rodriguez, Balma Boira-Nacher, Maria Font-Alberich, Marcos Gambini-Castell, Gloria Olaso-Gonzalez, et al.

    Osteoporosis is a chronic disease that is characterized by a loss of bone density, which mainly affects the microstructure of the bones due to a decrease in bone mass, thereby making them more fragile and susceptible to fractures. Osteoporosis is currently considered one of the pandemics of the 21st century, affecting around 200 million people. Its most serious consequence is an increased risk of bone fractures, thus making osteoporosis a major cause of disability and even premature death in the elderly. In this review, we discuss its causes, the biochemical mechanisms of bone regeneration, risk factors, pharmacological treatments, prevention and the effects of diet, focusing in this case on compounds present in a diet that could have palliative and preventive effects and could be used as concomitant treatments to drugs, which are and should always be the first option. It should be noted as a concluding remark that non-pharmacological treatments such as diet and exercise have, or should have, a relevant role in supporting pharmacology, which is the recommended prescription today, but we cannot ignore that they can have a great relevance in the treatment of this disease.


  • Open Access

    Osteoporosis: Causes, Mechanisms, Treatment and Prevention. Role of Dietary Compounds

    by Kristine Stromsnes, Cristian Martinez, Silvana Soto, Erika Ria Ulrika Kajander, Remus Lupu, Mónica Pozo-Rodríguez, Balma Boira, Gloria Olaso-Gonzalez, Maria Carmen Gomez-Cabrera, Juan Gambini

    Osteoporosis is a chronic disease that is characterized by a loss of bone density, mainly affecting the microstructure of the bones, due to a decrease in bone mass, thereby making them more fragile and susceptible to fractures. Osteoporosis is currently considered one of the pandemics of the 21st century, affecting around 200 million people. Its most serious consequence is an increased risk of bone fractures, thus making osteoporosis a major cause of disability and even premature death in the elderly. In this review we discuss causes, biochemical mechanisms of bone regeneration, risk factors, pharmacological treatments, prevention and effects of diet, focusing in this case on compounds present in the diet that could have palliative and preventive effects and could be used as concomitant treatments to drugs, which are and should always be the first option. It should be noted as concluding remarks that non-pharmacological treatments such as diet and exercise have, or should have, a relevant role in supporting pharmacology, which is the recommended prescription today, but we cannot ignore that they can have a great relevance in the treatment of this disease.